Picture of Bristol-Myers Squibb logo

CELG RT — Bristol-Myers Squibb News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapSuper Stock

Evotec rises after second FDA IND acceptance in Bristol Myers Squibb partnership

BUZZ-Evotec rises after second FDA IND acceptance in Bristol Myers Squibb partnership

** Shares in Evotec EVTG.DE rise 3.7% in early Frankfurt trade after the drug discovery company said its protein degradation partnership with Bristol Myers Squibb BMY.N has received a second FDA Investigational New Drug acceptance

** Company says the second investigational candidate, a cereblon E3 ligase modulator, is expected to enter a Phase 1 clinical trial in 2027

** First candidate from the partnership entered Phase 1 testing in advanced clear cell renal cell carcinoma in March 2026

** Up to the previous session's close, shares were down 49.9%​ YTD


(Reporting by Basile Day)

((Basile.Day@thomsonreuters.com))

Recent news on Bristol-Myers Squibb

See all news